Oxford Global R&D Series: VIRTUAL
About the event: Oxford Global R&D Series
POSTPONED to 29-30 July 2020 as a virtual event
The R&D Series features 3 outstanding programmes bringing together Europe’s most successful pharmaceutical organisations, top biotech companies and internationally renowned academic institutions specialising in therapeutic areas. The event includes over 100 cutting-edge presentations and workshops, over 8 hours of valuable networking sessions, and an exhibition hall showcasing 40 vendor companies.
Taros’ participants
Taros’ Drug Discovery Experts are invited to share their outstanding industry expertise with other professional from industry and academia
Dr. Dimitrios Tzalis, CEO as speaker on “the European Lead Factory (ELF) – the success story continues” within a virtual round table session on Drug Discovery Partnership Models Interactive Panel discussion and Open Address
Dr. Torsten Hoffmann, SVP Drug Discovery as invited Keynote Lecturer: “From Small Molecules, To Peptide Therapeutics And Oligoribonucleotides – 3 Short Stories In Drug Discovery”
Are you going to attend the event? contact us in advance to arrange a personal meeting
Drug Discovery Chemistry
Medicinal Chemistry
In Medicinal Chemistry research, we are working with a broadly experienced team on all biomolecular targets from any gene family in any therapeutic area…
Discovery Chemistry
Custom Synthesis
As a leading Contract Research Organization in Europe, Taros provides valuable contract discovery for synthetic organic chemistry, chemical process development, and…
